FR2987M - Médicament a base d'une nouvelle série de 8-[2-(1,4-benzodioxannyl)-méthyl]-1,3,8-triazaspiro (4,5)décanes, ainsi que de leurs sels. - Google Patents

Médicament a base d'une nouvelle série de 8-[2-(1,4-benzodioxannyl)-méthyl]-1,3,8-triazaspiro (4,5)décanes, ainsi que de leurs sels.

Info

Publication number
FR2987M
FR2987M FR948242A FR948242A FR2987M FR 2987 M FR2987 M FR 2987M FR 948242 A FR948242 A FR 948242A FR 948242 A FR948242 A FR 948242A FR 2987 M FR2987 M FR 2987M
Authority
FR
France
Prior art keywords
benzodioxannyl
decanes
triazaspiro
salts
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR948242A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of FR2987M publication Critical patent/FR2987M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Wire Processing (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR948242A 1962-06-22 1963-09-20 Médicament a base d'une nouvelle série de 8-[2-(1,4-benzodioxannyl)-méthyl]-1,3,8-triazaspiro (4,5)décanes, ainsi que de leurs sels. Active FR2987M (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20462362A 1962-06-22 1962-06-22
FR939044 1963-06-22

Publications (1)

Publication Number Publication Date
FR2987M true FR2987M (fr) 1964-12-07

Family

ID=22758700

Family Applications (6)

Application Number Title Priority Date Filing Date
FR1573808D Expired FR1573808A (fr) 1962-06-22 1963-06-22
FR948241A Active FR2986M (fr) 1962-06-22 1963-09-20 Médicament a base de nouveaux 1-aryl-4-oxo-8-aralcoyle-1,3,8-triazaspiro(4,5)décanes, ainsi que leurs sels a action analgésique.
FR948240A Active FR3043M (fr) 1962-06-22 1963-09-20 Médicament a base d'une nouvelle série de 1-aryl-4-oxo-1,3,8-triazaspiro-(4,5)-décanes, substitués en position 8 ou leurs sels pour le traitement d'affections mentales.
FR948244A Active FR3059M (fr) 1962-06-22 1963-09-20 Médicament pour le traitement des troubles mentaux et cardiovasculaires contenant une nouvelle série de 1-phényl-4-oxo-1,3,8-triazaspiro-[4,5]-décanes ou leurs sels.
FR948242A Active FR2987M (fr) 1962-06-22 1963-09-20 Médicament a base d'une nouvelle série de 8-[2-(1,4-benzodioxannyl)-méthyl]-1,3,8-triazaspiro (4,5)décanes, ainsi que de leurs sels.
FR948243A Active FR2988M (fr) 1962-06-22 1963-09-20 Médicament pour le traitement d'affections mentales et pour combattre la douleur, a base d'une nouvelle série de 1-phényl-4-oxo-8-(aryl-pentényl)-1,3,8-triazaspiro (4,5) décanes.

Family Applications Before (4)

Application Number Title Priority Date Filing Date
FR1573808D Expired FR1573808A (fr) 1962-06-22 1963-06-22
FR948241A Active FR2986M (fr) 1962-06-22 1963-09-20 Médicament a base de nouveaux 1-aryl-4-oxo-8-aralcoyle-1,3,8-triazaspiro(4,5)décanes, ainsi que leurs sels a action analgésique.
FR948240A Active FR3043M (fr) 1962-06-22 1963-09-20 Médicament a base d'une nouvelle série de 1-aryl-4-oxo-1,3,8-triazaspiro-(4,5)-décanes, substitués en position 8 ou leurs sels pour le traitement d'affections mentales.
FR948244A Active FR3059M (fr) 1962-06-22 1963-09-20 Médicament pour le traitement des troubles mentaux et cardiovasculaires contenant une nouvelle série de 1-phényl-4-oxo-1,3,8-triazaspiro-[4,5]-décanes ou leurs sels.

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR948243A Active FR2988M (fr) 1962-06-22 1963-09-20 Médicament pour le traitement d'affections mentales et pour combattre la douleur, a base d'une nouvelle série de 1-phényl-4-oxo-8-(aryl-pentényl)-1,3,8-triazaspiro (4,5) décanes.

Country Status (9)

Country Link
BE (1) BE633914A (fr)
CH (1) CH462835A (fr)
DE (1) DE1470125C3 (fr)
DK (1) DK119880B (fr)
FI (1) FI46967C (fr)
FR (6) FR1573808A (fr)
GB (1) GB1043141A (fr)
NO (1) NO117368B (fr)
SE (1) SE311019B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080328A (en) * 1971-07-13 1978-03-21 Sumitomo Chemical Company, Limited N-substituted heterocyclic derivatives and preparation thereof
BE792187A (fr) * 1971-12-03 1973-03-30 Sumitomo Chemical Co Nouveaux derives d'alkylamines
US4066772A (en) * 1975-07-21 1978-01-03 Janssen Pharmaceutica N.V. 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds
NZ181256A (en) * 1975-07-21 1978-04-28 Janssen Pharmaceutica Nv 1-(w-benzazol-11-ylalkyl)-piperidine derivatives and pharmaceutical compositions containing certain of these derivatives
DK139684A (da) * 1983-04-11 1984-10-12 Janssen Pharmaceutica Nv N-aryl-alpha-amino-carboxamider
US5244902A (en) * 1989-08-21 1993-09-14 Beth Israel Hospital Association Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
US5703088A (en) * 1989-08-21 1997-12-30 Beth Israel Deaconess Medical Center, Inc. Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
US5574041A (en) * 1990-03-16 1996-11-12 Beth Israel Hospital Association Use of spiperone derivatives as immunosuppressant agents
US5693645A (en) * 1992-12-23 1997-12-02 Beth Israel Deaconess Medical Center, Inc. Use of spiperone or spiperone derivatives as immunosuppressant agents
DE19610397A1 (de) * 1996-03-16 1997-09-18 Krewel Meuselbach Gmbh Gewinnung von Fluspirilen-Suspensionen
WO1999059997A1 (fr) * 1998-05-18 1999-11-25 Novo Nordisk A/S Nouvelles 1,3,8-triazaspiro[4.5]decanones possedant une affinite elevee pour les sous-types du recepteur opioide
US6277991B1 (en) 1998-05-18 2001-08-21 Novo Nordisk A/S 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
US6262066B1 (en) * 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
EP0997464B1 (fr) * 1998-10-23 2005-02-16 Pfizer Inc. 1,3,8-Triazaspiro[4,5] decanones utiles comme agonistes du récepteur orl1
US7459461B2 (en) 2001-10-19 2008-12-02 Ortho-Mcneil Pharmaceutical, Inc. Phosphonic acid compounds as inhibitors of serine proteases
DE102005038141A1 (de) * 2005-08-12 2007-02-15 Grünenthal GmbH Substituierte 8-(3-Aminopropyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-on-Derivate
ES2612471T3 (es) * 2010-06-18 2017-05-17 Altos Therapeutics, LLC Antagonistas D2, métodos de síntesis y métodos de uso
IT201800007580A1 (it) * 2018-07-27 2020-01-27 Maria Cecilia Hospital Spa Composti 1,3,8-triazaspiro e loro uso come medicamenti

Also Published As

Publication number Publication date
CH462835A (de) 1968-09-30
DE1470125A1 (de) 1969-05-08
FR3043M (fr) 1965-01-04
SE311019B (fr) 1969-05-27
DE1470125B2 (fr) 1979-10-31
FR1573808A (fr) 1969-07-11
FR2986M (fr) 1964-12-07
BE633914A (fr)
GB1043141A (en) 1966-09-21
NO117368B (fr) 1969-08-04
DE1470125C3 (de) 1980-07-10
FI46967C (fi) 1973-08-10
FR2988M (fr) 1964-12-07
FR3059M (fr) 1965-01-11
DK119880B (da) 1971-03-08
FI46967B (fr) 1973-05-02

Similar Documents

Publication Publication Date Title
FR2987M (fr) Médicament a base d'une nouvelle série de 8-[2-(1,4-benzodioxannyl)-méthyl]-1,3,8-triazaspiro (4,5)décanes, ainsi que de leurs sels.
LU56481A1 (fr) Procédé de préparation de nouvelles résines thermostables
FR3806M (fr) Médicament a base d'un dérivé de la quinazolone-(4).
OA02865A (fr) Procédé de préparation d'isothiocyano-benzazoles.
FR1836M (fr) Médicament a base de dérivés de la β-carboline.
FR3769M (fr) Médicament a base de dérivés d'imidazolidone.
FR3681M (fr) Médicament a base de composés hétérocycliques.
CH486427A (fr) Procédé de préparation d'amidines aromatiques N. substituées
OA03402A (fr) Procédé de préparation de nouvelles compositions anthelminthiques.
FR3517M (fr) Médicament a base de compositions vitaminées.
OA03879A (fr) Procédé de préparation de 2-alcoxy-4,5-azimido benzamides.
OA03357A (fr) Procédé de préparation de nouvelles chloroquinoléines.
FR3516M (fr) Médicament a base de compositions vitaminées.
FR3348M (fr) Médicament a base d'un nouveau dérivé de la 5.6-dihydromorphanthridine.
FR2944M (fr) Médicament pour le traitement de la toux a base de 2-amino-6-méthylheptane.
FR2886M (fr) Médicament a base de dérivés de l'acide anthranilique.
FR3202M (fr) Médicament a base de dérivé de théophylline.
OA02815A (fr) Procédé de préparation de nouvelles diphényl-pyridazones.
OA03359A (fr) Procédé de préparation de nouvelles chloroquinoléines.
FR3766M (fr) Médicament a base de dérivés de naphtamidines.
FR3755M (fr) Médicament a base de nouvelles pénicillines.
FR1274572A (fr) Procédé de préparation de résines échangeuses d'anions, produits en résultant et leurs applications
FR1738M (fr) Médicament a base de bis- (β-carbhydrazido-éthyl)-sulfone pour le traitement de la bilharziose.
FR3478M (fr) Médicament a base de dérivés de l'imidazole.
FR1282744A (fr) Procédé de préparation de l'aldéhyde de la vitamine a.